Alkermes (NASDAQ:ALKS) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.52) by 23.08 percent. This is a 407.69 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $392.911 million which beat the analyst consensus estimate of $359.848 million by 9.19 percent. This is a 28.19 percent increase over sales of $306.510 million the same period last year.